![]() |
市場調查報告書
商品編碼
1964070
鼻竇擴張器市場-全球產業規模、佔有率、趨勢、機會、預測:按產品類型、最終用戶、地區和競爭對手分類,2021-2031年Sinus Dilation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End user, By Region & Competition, 2021-2031F |
||||||
全球鼻竇擴張器市場預計將從 2025 年的 28.1 億美元成長到 2031 年的 38.4 億美元,複合年成長率為 5.35%。
這些設備主要包括球囊式鼻竇擴張系統和鼻竇支架,是專門用於擴張阻塞的鼻竇通道、恢復慢性鼻竇炎患者自然引流功能的醫療設備。與功能性內視鏡鼻竇手術不同,這些方案無需切除大量組織即可機械性擴張鼻腔。市場成長趨勢的根本驅動力是慢性呼吸系統疾病發病率的上升以及患者對微創門診手術(可縮短復原時間)日益成長的偏好。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 28.1億美元 |
| 市場規模:2031年 | 38.4億美元 |
| 複合年成長率:2026-2031年 | 5.35% |
| 成長最快的細分市場 | 球囊鼻竇成形術系統 |
| 最大的市場 | 北美洲 |
然而,由於先進擴張手術的高成本以及新興市場對醫療設備認證的嚴格監管要求,該市場面臨巨大的阻力。儘管需要治療的人群不斷成長,但這些經濟和官僚障礙限制了治療的可近性。根據美國耳鼻喉頭頸外科學會基金會預測,到2025年,美國成年人中將有11.6%患有慢性鼻竇炎,預計每年將導致約410萬次門診就診。這些數據凸顯了不斷成長的臨床需求與財務和監管挑戰所帶來的限制之間的差距。
全球慢性鼻竇炎 (CRS) 盛行率的上升是鼻竇擴張器材市場擴張的主要促進因素。環境因素和人口老化導致全球感染率上升,進而增加了對球囊鼻竇成形術等有效外科手術介入的需求。日益成長的患者負擔強烈表明,除了標準藥物治療外,還需要更多可擴展的治療方法,從而擴大了適合機械擴張的患者群體。美國國立衛生研究院 (NIH) 於 2024 年 11 月進行的一項系統性回顧發現,全球 CRS 的總盛行率為 8.71%,凸顯了鼻竇阻塞患者群體的龐大規模。
同時,由於市場正朝著更經濟高效的門診手術方向發生重大轉變,醫療市場也正在經歷重大變革。健康保險公司和醫療服務提供者越來越重視在門診進行的微創技術,與手術室手術相比,這些技術能夠顯著降低成本。小型導航設備的出現也推動了這一趨勢。 2024年9月發表在《Scholastica》雜誌上的一項研究表明,目前約有48.50%的球囊鼻竇成形術是在門診進行的,這充分體現了治療環境的轉變。為了凸顯這一趨勢的商業性影響,Smith+Nephew公司在2025年2月發布的報告顯示,其耳鼻喉科業務部門在第四季度實現了19.4%的潛在收入成長,這主要得益於手術量的回升。
與先進擴張手術相關的高昂費用是全球鼻竇擴張器械市場的主要阻礙因素。這項經濟障礙顯著限制了病患的就醫途徑,尤其是在健保報銷模式不足以覆蓋一次性球囊導管和支架系統高昂成本的地區。當經濟負擔轉嫁給醫療服務提供者或患者需要自付高額費用時,這些微創手術的普及往往會被延遲,迫使患者依賴成本較低的傳統手術。
此外,保險報銷結構的改變也為診所鼻竇手術的經濟可行性帶來了額外壓力。據美國耳鼻喉頭頸外科學會稱,美國醫療保險和醫療補助服務中心已承諾在2024年將轉換係數降低約3.37%,這將有效降低醫生服務的支付水準。財政支持的減少使得醫療機構不願儲備昂貴的擴張裝置,導致整體採購量下降,儘管這些技術具有明顯的臨床優勢,但市場成長卻受到阻礙。
人工智慧增強型手術導引系統的整合正在從根本上改變手術環境,顯著提升複雜鼻竇手術的精確度。外科醫師正在即時運用擴增實境(AR)疊加技術和機器學習演算法,大幅降低功能性內視鏡鼻竇手術(FESS)中眼眶和顱底相關併發症的風險。這種技術融合使得在畸形解剖結構內進行安全導航成為可能,並推動了電動導航主機在門診和住院環境中的應用。對這些技術的強勁需求也體現在行業業績上:史賽克公司報告稱,其外科和神經技術部門2025年10月的淨銷售額成長了14.4%,達到38億美元,凸顯了先進導航解決方案的快速普及。
同時,混合式鼻竇擴張術的應用日益廣泛,該技術結合了球囊擴張術的組織保護效果和傳統組織切除術的整體性。這項技術利用電動器材切除頑固性息肉和篩竇隔膜,同時擴張主要鼻竇開口,從而克服了單一擴張術的局限性,確保了廣泛病變患者的通暢性。這一趨勢推動了對能夠同時支援電動切除和機械擴張的多功能手術平台的持續需求。為了佐證這一成長,史密斯醫療(Smith & Nephew)2025年11月發布的報告顯示,其運動醫學和耳鼻喉科部門實現了5.1%的潛在收入成長,這主要得益於對這種綜合鼻竇修復策略所需器械的強勁需求。
The Global Sinus Dilation Devices Market is projected to expand from USD 2.81 Billion in 2025 to USD 3.84 Billion by 2031, registering a CAGR of 5.35%. These devices, primarily consisting of balloon sinus dilation systems and sinus stents, are specialized medical instruments used to widen obstructed sinus pathways and restore natural drainage in patients with chronic rhinosinusitis. Unlike traditional functional endoscopic sinus surgery, these solutions mechanically expand nasal passages without requiring extensive tissue removal. The market's upward trajectory is fundamentally underpinned by the increasing incidence of chronic respiratory conditions and a growing preference for minimally invasive outpatient procedures that offer patients shorter recovery periods.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.81 Billion |
| Market Size 2031 | USD 3.84 Billion |
| CAGR 2026-2031 | 5.35% |
| Fastest Growing Segment | Balloon Sinuplasty System |
| Largest Market | North America |
However, the market faces significant headwinds due to the high costs of advanced dilation procedures and stringent regulatory requirements for device approval in emerging markets. These economic and bureaucratic barriers restrict accessibility, even as the population requiring treatment grows. According to the American Academy of Otolaryngology-Head and Neck Surgery Foundation, chronic rhinosinusitis is expected to affect 11.6% of adults in the United States in 2025, leading to approximately 4.1 million annual ambulatory visits. This data highlights the disparity between the growing clinical need and the limitations imposed by financial and regulatory challenges.
Market Driver
The escalating global prevalence of Chronic Rhinosinusitis (CRS) acts as the primary engine driving the expansion of the sinus dilation devices market. As environmental factors and aging populations contribute to rising infection rates worldwide, the demand for effective surgical interventions, such as balloon sinuplasty, is intensifying. This increasing patient burden creates a critical need for scalable treatment options beyond standard medical management, thereby expanding the population eligible for mechanical dilation. According to a systematic review by the National Institutes of Health (NIH) in November 2024, the global pooled prevalence of CRS was identified at 8.71%, underscoring the massive scale of the population suffering from sinonasal obstruction.
Concurrently, the market is undergoing a significant transformation due to a decisive shift toward cost-effective office-based procedures. Healthcare payers and providers are increasingly prioritizing minimally invasive techniques performed in outpatient settings, which significantly lower costs compared to operating room surgeries, a trend supported by the advent of compact, navigation-enabled devices. A study published via Scholastica in September 2024 noted that approximately 48.50% of balloon sinuplasty cases are now conducted in office settings, illustrating this migration of care. Highlighting the commercial impact of this trend, Smith+Nephew reported in February 2025 that their ENT business segment achieved 19.4% underlying revenue growth in the fourth quarter, fueled by recovering procedure volumes.
Market Challenge
The substantial expense linked to advanced dilation procedures represents a major constraint on the global sinus dilation devices market. This financial obstacle severely limits patient access, especially in regions where reimbursement models fail to adequately cover the premium costs of single-use balloon catheters and stent systems. When the financial burden is shifted to healthcare providers or necessitates high out-of-pocket payments from patients, the adoption of these minimally invasive interventions slows, often compelling a reliance on less expensive, traditional surgical options.
Moreover, evolving reimbursement structures are placing additional pressure on the economic viability of office-based sinus procedures. According to the American Academy of Otolaryngology-Head and Neck Surgery, the Centers for Medicare & Medicaid Services finalized a conversion factor reduction of roughly 3.37 percent in 2024, effectively lowering payment rates for physician services. This decrease in financial support deters medical practices from maintaining expensive inventories of dilation devices, thereby curtailing overall procurement volumes and hindering market growth despite the clear clinical advantages of these technologies.
Market Trends
The integration of AI-augmented surgical navigation systems is fundamentally transforming the procedural environment by improving precision during complex sinus interventions. Surgeons are increasingly adopting augmented reality (AR) overlays and machine learning algorithms to map drainage pathways in real-time, which significantly mitigates the risk of complications involving the orbit or skull base during functional endoscopic sinus surgery (FESS). This technological convergence facilitates safer navigation through distorted anatomies, driving the adoption of powered navigation consoles in both ambulatory and hospital settings. The strong demand for these technologies is reflected in industry performance; Stryker reported in October 2025 that its MedSurg and Neurotechnology segment grew net sales by 14.4% to reach $3.8 billion, highlighting the rapid uptake of advanced navigation solutions.
Simultaneously, there is a rising adoption of hybrid sinus dilation techniques that merge the tissue-preservation advantages of balloon sinuplasty with the comprehensive nature of traditional tissue removal. This approach resolves the limitations of standalone dilation by utilizing powered instruments to eliminate resistant polyps or ethmoid partitions while dilating major sinus ostia, ensuring lasting patency for patients with extensive disease. This trend fosters sustained demand for versatile surgical platforms capable of supporting both powered resection and mechanical dilation. Validating this growth, Smith+Nephew's November 2025 report indicated that their Sports Medicine & ENT unit achieved 5.1% underlying revenue growth, driven by the resilient consumption of instruments essential for these comprehensive sinus repair strategies.
Report Scope
In this report, the Global Sinus Dilation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Sinus Dilation Devices Market.
Global Sinus Dilation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: